Abstract
The acute toxicity of mango leaves extract (MLE) at the maximal dose (18.4 g/kg) was studied in ICR mice and no abnormalities were detected during the experiment. The long-term studies at various doses of MLE (100 mg/kg, 300 mg/kg, and 900 mg/kg) in SD rats for 3 consecutive months revealed that, compared with the control group, rats in MLE treated groups showed slight body weight increase and higher fat weight; the serum TG and CHOL levels and the epididymis weight of male rats were a little higher; the serum K+ level of female rats was on the low side but the weights of liver, kidney, and adrenal gland were on the high side. In addition to this, no other obvious abnormalities were detected.
1. Introduction
Mango tree (Mangifera indica L.), a tropical plant belonging to Anacardiaceae, has been distributed worldwide as the most cultivated fruits in the tropics. Mango leaves were used for diabetes and asthma treatment in traditional Chinese medicine (TCM). Mango leaves contain phenolic constituents such as caffeic acid [1], polyphenols such as mangiferin and gallic acid [2], flavonoids [3], volatile compounds [4], and so forth. Pharmacology studies showed that the extract of mango leaves possesses many effects like antioxidant, antimicrobial, antihelminthic, antidiabetic, antiallergic, and so forth [5]. In previous study, we reported benzophenone C-glycosides with triglyceride accumulation inhibitory effects in adipocyte [6, 7]. We also reported that ethanol extract of mango leaves dose-dependently decreased serum glucose and triglyceride in KK-Ay mice, and mechanism on glucose and lipid homeostasis is mediated, at least in part, through PI3K/AKT and AMPK signaling pathway [8]. Although mango tree leaves were used for a long period in TCM clinic, there are few reports on the safety evaluations. In this study, we carried out the acute toxicity and long-term toxicity of mango leaves extract (MLE), aiming at providing reference basis for other safety evaluation studies and selecting clinical dosage.
2. Materials and Methods
2.1. Materials
2.1.1. Plant Material
In the present study, mango leaves were collected from Zhejiang Province, China, and identified by Dr. Tianxiang Li at Tianjin University of TCM as Mangifera indica L. Voucher specimen was deposited at the Academy of Traditional Chinese Medicine of Tianjin University of TCM
2.1.2. Animals
Forty ICR mice, half male and half female, weighted 18–21 g, and 48 SD rats, composed of male and female in half, weighted 117–160 g, were used in the study and feed in room of SPF grade laboratory. These animals were all provided by Vital River Laboratory Animal Technology Co., Ltd.
2.1.3. Instruments
PL203 electronic balance and ML203 electronic balance were purchased from Changzhou Mettler Toledo Instrument Co., Ltd. ADVIA2120 hematology analyzer was made by Germany Siemens Electrical Apparatus Ltd. ACL9000 coagulometer was made by American Beckman Coulter Inc. 7080 automatic biochemical analyzer was made by Japanese Hitachi Ltd.
2.2. Methods
2.2.1. Preparation of MLE
Dried mango leaves, collected from Hainan province of China, was extracted by 70% ethanol (1 g in 10 mL) under reflux for 2 h, and the residue was extracted under the same condition. The 70% ethanol solutions were combined together and further subjected to a D101 macroporous absorption resin column eluted with water, 15% ethanol. 15% ethanol fraction was concentrated and reextracted by 50% ethanol (50 degrees for 2 h). The 50% ethanol extract was dried under vacuum to obtain mango leaves extract, which contains 62% mangiferin (HPLC method). The final extract based on the above process was effective and has the functions of mango leaves.
2.2.2. Acute Toxicity of MLE in ICR Mice
Forty ICR mice of mixed sexes were randomly divided into two groups: MLE treated group and control group. Mice in MLE treated group were given MLE at the maximal dose of 18.4 g/kg by intragastric administration, in a volume of 0.1 mL per 10 g, twice a day with a 4 h interval, while the control group received an equal volume of deionized water. After oral administration, the various responses of mice including toxic reactions and mortality were observed and recorded every day for successive 14 days. At the end of the experiment, animals were executed for gross anatomy check. Evaluating and recording whether there were any obvious changes in major organs by macroscopic observation.
2.2.3. Long-Term Toxicity of MLE in SD Rats
(1) Group Setup and Administration. After seven days of stabilization, 48 SD rats of mixed sexes that have moderate body weight and body weight gain speed were selected for the study. Depending on the weight, they were randomly divided into four groups, including one blank group for control and three administration groups of different doses (100 mg/kg, 300 mg/kg, and 900 mg/kg) which are equivalent to 17.2, 51.7, and 155.2 times of clinical daily dose (5.8 mg/kg), respectively. Rats in MLE treated group were given MLE by intragastric administration at the corresponding dose, in a volume of 0.1 mL per 10 g, for 3 consecutive months (6 times a week), while the control group received an equal volume of deionized water. During the study, all rats were allowed access to food and water ad libitum.
(2) Observational Indices. After oral administration, observe the general symptom, such as appearance, behavior, glandular secretion, breathing, and so on. The body weight and food consumption of each animal were recorded weekly and the differences among groups were compared.
After 90 days of treatment, all the 48 SD rats were sacrificed, and blood samples were collected from the abdominal aorta for hematology and coagulation tests. The white blood corpuscles (WBC) count, red blood corpuscles (RBC) count, hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and prothrombin time (PT) were carried out.
Serum was separated by spinning the blood and was used for biochemical studies. ALT, AST, ALP, BUN, CREA, TP, ALB, GLU, CHOL, Na+, K+, and Cl− contents in serum and many other blood biochemical parameters were determined using the automatic biochemistry analyzer.
Organs (liver, heart, spleen, lung, kidney, brain, thymus, etc.) were collected from each sacrificed rat and weighed. The relative organ weights (organ/body weight ratio and organ/brain weight ratio) were calculated and compared with the value of the control.
2.2.4. Statistical Analysis
The intragroup difference of measurement data was detected with the t-test. The data obtained were subjected to SPSS NPar Tests Mann-Whitney Test. Values were expressed as the mean ± standard error and were considered statistically significant at P < 0.05.
3. Results and Discussion
3.1. Acute Toxicity
3.1.1. General Observation
During the course of the study, all the mice were healthy without any abnormal responses, and no distinct lesions were revealed anatomically.
3.1.2. Body Weight
After the second oral administration of MLE, the body weight of the mice in both of the two groups decreased slightly than before the first dose, and the control group decreased more, but there was no significant difference (P > 0.05). It is speculated that the body weight loss may result from the fasting between the two doses and the high drug concentration (the maximum dispensing concentration) that induced satiety may affect the short-time body weight change.
Throughout the recovery period, the animal weight, both of the two groups, showed a general increase, but in several mice it decreased a day after the treatment (one in control group and six in MLE treated group); and after fourteen-day treatment, five mice in MLE treated group showed a slight weight loss (less than 1 g). Speculated by the whole growth trend, we guess that the body weight change after one-day treatment, which was recovered three days later, may be associated with the drug's effect and the change after fourteen days was likely to be coursed by physiological fluctuations, but it produced no significant difference (P > 0.05) compared with control group (Table 1). As a result, the effect of MLE on mice body weight was not obvious.
Table 1.
Sex | Groups | Preceding the first dose | Preceding the second dose | After administration | |||
---|---|---|---|---|---|---|---|
Day 1 | Day 3 | Day 7 | Day 14 | ||||
♂ | Control | 20.84 ± 0.42 | 20.06 ± 0.40 | 21.72 ± 0.78 | 24.70 ± 0.81 | 28.06 ± 0.92 | 30.91 ± 1.02 |
Drug | 20.83 ± 0.71 | 20.31 ± 0.69 | 20.98 ± 1.28 | 24.13 ± 1.37 | 27.21 ± 1.52 | 29.94 ± 1.27 | |
| |||||||
♀ | Control | 19.27 ± 0.64 | 18.59 ± 0.59 | 19.42 ± 1.27 | 21.04 ± 1.36 | 22.99 ± 0.88 | 25.33 ± 1.05 |
Drug | 19.19 ± 0.73 | 18.81 ± 0.84 | 18.99 ± 0.97 | 20.99 ± 0.86 | 23.42 ± 1.31 | 24.42 ± 1.28 |
Ten mice in each group; no difference was considered to be significant between the two groups.
3.1.3. Gross Anatomy and Histopathological Examination
After a fourteen-day recovery, all the mice were executed for gross anatomy check. Because there were no gross lesions on major organs, no histopathological examination was conducted.
3.2. Long-Term Toxicity
3.2.1. General Observation
After three consecutive months of oral administration, all the animals showed no marked abnormalities during the study.
3.2.2. Body Weight and Food Consumption
The body weight of rats (presented in Table 2) in each group showed a steady increase trend, while MLE treated groups had a higher body-mass index than control group. However, there were no significant differences (P > 0.05), except in the female rats in low and medium dose groups at day 10 and in high dose group at days 21 and 49 (P < 0.05).
Table 2.
Sex | Time | n | Control group | n | Low dose group | n | Medium dose group | n | High dose group |
---|---|---|---|---|---|---|---|---|---|
♂ | 0 d | 18 | 149.1 ± 8.2 | 18 | 148.2 ± 8.6 | 18 | 147.6 ± 8.3 | 18 | 147.9 ± 7.9 |
3 d | 18 | 174.8 ± 10.9 | 18 | 172.3 ± 10.1 | 18 | 172.2 ± 10.1 | 18 | 169.6 ± 11.8 | |
7 d | 18 | 206.4 ± 14.1 | 18 | 200.0 ± 14.5 | 18 | 201.0 ± 13.6 | 18 | 202.9 ± 15.9 | |
10 d | 18 | 231.2 ± 17.0 | 18 | 227.7 ± 16.2 | 18 | 226.1 ± 15.3 | 18 | 227.5 ± 18.6 | |
14 d | 18 | 261.4 ± 20.2 | 18 | 260.6 ± 19.9 | 18 | 257.8 ± 18.7 | 18 | 259.8 ± 22.1 | |
17 d | 18 | 285.9 ± 22.8 | 18 | 284.4 ± 23.3 | 18 | 283.8 ± 21.2 | 18 | 285.3 ± 22.0 | |
21 d | 18 | 311.3 ± 24.1 | 18 | 312.2 ± 28.4 | 18 | 313.2 ± 23.6 | 18 | 316.0 ± 23.9 | |
24 d | 18 | 325.9 ± 26.6 | 18 | 331.4 ± 30.7 | 18 | 332.2 ± 25.0 | 18 | 336.4 ± 24.9 | |
28 d | 18 | 347.6 ± 31.4 | 18 | 353.6 ± 35.7 | 18 | 350.0 ± 25.9 | 18 | 359.4 ± 27.5 | |
31 d | 18 | 363.4 ± 34.9 | 18 | 370.1 ± 38.1 | 18 | 368.6 ± 28.1 | 18 | 377.1 ± 29.5 | |
35 d | 18 | 379.2 ± 38.2 | 18 | 388.1 ± 40.6 | 18 | 387.1 ± 31.6 | 18 | 396.2 ± 30.3 | |
42 d | 18 | 409.9 ± 44.1 | 18 | 418.0 ± 45.7 | 18 | 416.6 ± 34.7 | 18 | 425.0 ± 34.1 | |
49 d | 18 | 435.1 ± 46.5 | 18 | 443.2 ± 47.5 | 18 | 439.4 ± 35.4 | 18 | 448.4 ± 35.2 | |
56 d | 18 | 455.7 ± 51.1 | 18 | 465.7 ± 49.8 | 18 | 461.1 ± 38.3 | 18 | 471.5 ± 37.4 | |
63 d | 18 | 482.6 ± 51.2 | 18 | 493.8 ± 51.8 | 18 | 487.8 ± 40.8 | 18 | 498.1 ± 39.6 | |
70 d | 18 | 500.2 ± 51.8 | 18 | 508.7 ± 54.0 | 18 | 497.3 ± 44.6 | 18 | 516.4 ± 43.2 | |
77 d | 18 | 516.8 ± 53.5 | 18 | 525.1 ± 57.8 | 18 | 517.6 ± 45.6 | 18 | 531.8 ± 44.9 | |
84 d | 18 | 535.9 ± 56.1 | 18 | 538.2 ± 60.7 | 18 | 532.8 ± 47.5 | 18 | 546.9 ± 47.4 | |
| |||||||||
♀ | 0 d | 18 | 132.4 ± 6.7 | 18 | 134.1 ± 7.3 | 18 | 133.0 ± 7.2 | 18 | 131.2 ± 7.4 |
3 d | 18 | 146.1 ± 7.7 | 18 | 149.4 ± 7.9 | 18 | 148.2 ± 9.0 | 18 | 147.8 ± 9.9 | |
7 d | 18 | 159.3 ± 8.2 | 18 | 163.4 ± 8.7 | 18 | 165.1 ± 12.5 | 18 | 163.9 ± 13.1 | |
10 d | 18 | 168.2 ± 9.3 | 18 | 176.4 ± 9.0* | 18 | 176.3 ± 12.6* | 18 | 174.8 ± 14.6 | |
14 d | 18 | 181.5 ± 11.3 | 18 | 186.3 ± 9.6 | 18 | 186.9 ± 15.2 | 18 | 188.1 ± 15.3 | |
17 d | 18 | 194.3 ± 11.4 | 18 | 197.0 ± 11.9 | 18 | 199.2 ± 17.6 | 18 | 202.6 ± 18.7 | |
21 d | 18 | 204.3 ± 13.4 | 18 | 207.8 ± 12.0 | 18 | 211.1 ± 20.9 | 18 | 216.8 ± 21.3* | |
24 d | 18 | 212.6 ± 16.3 | 18 | 215.1 ± 13.0 | 18 | 222.1 ± 19.8 | 18 | 224.0 ± 24.7 | |
28 d | 18 | 221.4 ± 18.4 | 18 | 223.1 ± 14.8 | 18 | 232.0 ± 21.9 | 18 | 233.8 ± 25.1 | |
31 d | 18 | 229.7 ± 16.9 | 18 | 232.3 ± 13.0 | 18 | 239.9 ± 23.7 | 18 | 243.2 ± 24.7 | |
35 d | 18 | 237.2 ± 17.5 | 18 | 241.8 ± 14.3 | 18 | 248.7 ± 25.3 | 18 | 250.4 ± 23.6 | |
42 d | 18 | 250.4 ± 22.2 | 18 | 255.6 ± 15.0 | 18 | 262.2 ± 27.5 | 18 | 265.7 ± 24.5 | |
49 d | 18 | 258.9 ± 18.2 | 18 | 263.6 ± 17.3 | 18 | 272.9 ± 29.3 | 18 | 274.6 ± 24.1* | |
56 d | 18 | 265.7 ± 18.3 | 18 | 267.8 ± 17.5 | 18 | 280.1 ± 26.5 | 18 | 276.8 ± 26.8 | |
63 d | 18 | 279.2 ± 20.2 | 18 | 284.2 ± 16.8 | 18 | 292.8 ± 29.6 | 18 | 290.1 ± 26.8 | |
70 d | 18 | 284.6 ± 21.1 | 18 | 290.4 ± 14.5 | 18 | 296.5 ± 30.3 | 18 | 295.1 ± 29.1 | |
77 d | 18 | 290.0 ± 19.8 | 18 | 294.4 ± 14.4 | 18 | 302.6 ± 33.4 | 18 | 303.3 ± 26.8 | |
84 d | 18 | 295.4 ± 19.1 | 18 | 300.6 ± 14.3 | 18 | 306.1 ± 29.6 | 18 | 308.4 ± 28.8 |
∗Means P < 0.05; n means the number of animals.
The food consumption of rats (presented in Table 3) in each group showed some fluctuation, but there were no significant differences among those groups (P > 0.05).
Table 3.
Sex | Time | Cage number | n | Control group | n | Low dose group | n | Medium dose group | n | High dose group |
---|---|---|---|---|---|---|---|---|---|---|
♂ | 0 d | 3 | 18 | 22.7 ± 0.9 | 18 | 23.1 ± 0.3 | 18 | 23.4 ± 0.8 | 18 | 22.4 ± 2.5 |
7 d | 3 | 18 | 25.5 ± 2.4 | 18 | 26.2 ± 1.1 | 18 | 26.5 ± 0.7 | 18 | 25.6 ± 0.8 | |
14 d | 3 | 18 | 28.1 ± 1.4 | 18 | 28.4 ± 0.2 | 18 | 27.9 ± 1.3 | 18 | 27.9 ± 1.5 | |
21 d | 3 | 18 | 28.4 ± 2.2 | 18 | 31.2 ± 1.5 | 18 | 28.8 ± 2.9 | 18 | 30.6 ± 1.0 | |
28 d | 3 | 18 | 28.8 ± 2.9 | 18 | 30.6 ± 1.2 | 18 | 30.7 ± 0.4 | 18 | 31.9 ± 0.2 | |
35 d | 3 | 18 | 29.7 ± 2.3 | 18 | 30.9 ± 2.1 | 18 | 31.6 ± 0.4 | 18 | 30.7 ± 1.2 | |
42 d | 3 | 18 | 30.1 ± 2.3 | 18 | 29.6 ± 1.3 | 18 | 30.4 ± 0.7 | 18 | 29.6 ± 1.4 | |
49 d | 5 | 18 | 32.4 ± 3.7 | 18 | 31.5 ± 1.1 | 18 | 30.6 ± 1.5 | 18 | 30.6 ± 3.0 | |
56 d | 5 | 18 | 32.5 ± 2.0 | 18 | 33.4 ± 1.1 | 18 | 30.7 ± 0.7 | 18 | 31.3 ± 2.2 | |
63 d | 5 | 18 | 32.7 ± 1.8 | 18 | 33.2 ± 2.3 | 18 | 32.6 ± 1.3 | 18 | 34.6 ± 2.2 | |
70 d | 5 | 18 | 33.7 ± 3.4 | 18 | 33.6 ± 2.1 | 18 | 33.7 ± 1.8 | 18 | 33.1 ± 2.4 | |
77 d | 5 | 18 | 32.3 ± 2.6 | 18 | 32.6 ± 4.0 | 18 | 32.4 ± 2.3 | 18 | 33.7 ± 2.4 | |
84 d | 5 | 18 | 30.7 ± 3.1 | 18 | 31.1 ± 1.2 | 18 | 29.8 ± 1.2 | 18 | 30.7 ± 2.1 | |
| ||||||||||
♀ | 0 d | 3 | 18 | 17.6 ± 0.8 | 18 | 18.1 ± 0.5 | 18 | 18.8 ± 1.5 | 18 | 18.6 ± 0.9 |
7 d | 3 | 18 | 18.9 ± 1.2 | 18 | 17.3 ± 0.6 | 18 | 19.7 ± 1.5 | 18 | 17.9 ± 0.8 | |
14 d | 3 | 18 | 20.0 ± 1.8 | 18 | 18.9 ± 0.5 | 18 | 21.4 ± 1.4 | 18 | 20.8 ± 1.1 | |
21 d | 3 | 18 | 21.9 ± 2.4 | 18 | 22.1 ± 1.1 | 18 | 22.4 ± 3.2 | 18 | 21.4 ± 2.3 | |
28 d | 3 | 18 | 19.4 ± 3.6 | 18 | 22.1 ± 1.2 | 18 | 22.5 ± 1.5 | 18 | 22.7 ± 1.2 | |
35 d | 3 | 18 | 21.3 ± 0.4 | 18 | 21.1 ± 1.2 | 18 | 22.6 ± 1.7 | 18 | 23.1 ± 2.0 | |
42 d | 3 | 18 | 22.2 ± 1.2 | 18 | 22.8 ± 1.9 | 18 | 23.4 ± 1.7 | 18 | 24.3 ± 1.0 | |
49 d | 3 | 18 | 22.5 ± 2.4 | 18 | 24.6 ± 1.4 | 18 | 23.2 ± 3.0 | 18 | 22.1 ± 0.8 | |
56 d | 3 | 18 | 21.7 ± 1.0 | 18 | 22.1 ± 1.1 | 18 | 22.8 ± 2.1 | 18 | 21.6 ± 0.4 | |
63 d | 3 | 18 | 22.0 ± 1.3 | 18 | 22.3 ± 1.0 | 18 | 22.2 ± 2.2 | 18 | 20.8 ± 1.3 | |
70 d | 3 | 18 | 23.9 ± 1.8 | 18 | 23.6 ± 0.9 | 18 | 23.8 ± 2.5 | 18 | 22.7 ± 1.3 | |
77 d | 3 | 18 | 21.8 ± 2.0 | 18 | 23.8 ± 1.4 | 18 | 22.4 ± 2.8 | 18 | 21.1 ± 1.4 | |
84 d | 3 | 18 | 20.3 ± 1.1 | 18 | 21.9 ± 0.6 | 18 | 21.2 ± 1.3 | 18 | 21.5 ± 1.9 |
n means the number of animals.
As a result, after a long-term administration of MLE, the effects on the body weight and food consumption of rats were not obvious.
3.2.3. Hematology and Coagulation Function
After a 3-month of oral administration of MLE, some hematology indices and coagulation function of rats were determined as were shown in Table 4.
Table 4.
Sex | Parameters | Control group (n = 6) | Low dose group (n = 6) | Medium dose group (n = 6) | High dose group (n = 6) |
---|---|---|---|---|---|
♂ | WBC (×109/L) | 10.08 ± 1.29 | 12.47 ± 3.03 | 11.66 ± 2.32 | 11.58 ± 3.36 |
Neut (%) | 12.06 ± 1.38 | 15.48 ± 4.58 | 12.33 ± 2.89 | 12.30 ± 5.21 | |
Lymph (%) | 83.32 ± 1.64 | 79.10 ± 4.80 | 81.78 ± 3.14 | 81.85 ± 5.50 | |
Mono (%) | 2.58 ± 0.64 | 3.02 ± 0.66 | 2.95 ± 0.71 | 3.00 ± 0.87 | |
Eos (%) | 1.24 ± 0.33 | 1.10 ± 0.18 | 1.33 ± 0.56 | 1.65 ± 0.32 | |
RBC (×1012/L) | 9.24 ± 0.36 | 9.52 ± 0.59 | 9.57 ± 0.36 | 9.79 ± 0.34∗ | |
HGB (g/L) | 167.40 ± 6.80 | 166.17 ± 9.33 | 162.33 ± 4.27 | 167.50 ± 3.15 | |
HCT (%) | 48.32 ± 1.57 | 48.40 ± 3.48 | 48.00 ± 1.08 | 49.87 ± 1.64 | |
MCV (fL) | 52.28 ± 0.55 | 50.82 ± 0.77∗∗ | 50.20 ± 1.44∗ | 50.98 ± 2.29 | |
MCH (pg) | 18.16 ± 1.10 | 17.50 ± 0.67 | 16.98 ± 0.57∗ | 17.13 ± 0.72 | |
MCHC (g/L) | 347.20 ± 20.66 | 344.50 ± 13.40 | 338.33 ± 3.33 | 336.67 ± 5.99 | |
PLT (×109/L) | 1145.00 ± 121.6 | 1208.00 ± 158.73 | 1216.17 ± 98.95 | 1217.00 ± 104.08 | |
Retic (‰) | 2.96 ± 0.42 | 2.80 ± 0.43 | 2.96 ± 0.36 | 2.56 ± 0.40 | |
PT (s) | 16.04 ± 1.13 | 16.48 ± 2.71 | 15.68 ± 0.93 | 16.15 ± 1.22 | |
| |||||
♀ | WBC (×109/L) | 5.10 ± 1.44 | 5.97 ± 0.89 | 5.77 ± 1.01 | 5.45 ± 1.41 |
Neut (%) | 15.92 ± 2.58 | 15.62 ± 3.79 | 17.77 ± 2.32 | 16.38 ± 5.62 | |
Lymph (%) | 78.27 ± 2.64 | 78.38 ± 4.06 | 76.48 ± 2.70 | 78.08 ± 7.14 | |
Mono (%) | 2.57 ± 0.46 | 3.02 ± 0.58 | 2.95 ± 1.11 | 2.73 ± 1.18 | |
Eos (%) | 2.00 ± 0.40 | 1.60 ± 0.67 | 1.73 ± 0.29 | 1.97 ± 0.58 | |
RBC (×1012/L) | 8.63 ± 0.23 | 8.81 ± 0.56 | 8.55 ± 0.26 | 8.64 ± 0.48 | |
HGB (g/L) | 159.17 ± 2.93 | 158.50 ± 7.34 | 157.50 ± 2.88 | 159.17 ± 6.55 | |
HCT (%) | 46.53 ± 1.29 | 46.52 ± 2.61 | 46.28 ± 1.16 | 46.45 ± 2.14 | |
MCV (fL) | 53.92 ± 1.66 | 52.83 ± 1.26 | 54.18 ± 1.70 | 53.78 ± 0.95 | |
MCH (pg) | 18.43 ± 0.46 | 18.05 ± 0.63 | 18.43 ± 0.37 | 18.47 ± 0.32 | |
MCHC (g/L) | 342.17 ± 5.78 | 341.33 ± 5.79 | 340.50 ± 6.06 | 343.50 ± 2.88 | |
PLT (×109/L) | 1134.67 ± 63.64 | 1268.33 ± 182.79 | 1211.17 ± 121.14 | 1197.83 ± 73.19 | |
Retic (‰) | 2.86 ± 0.71 | 2.45 ± 0.63 | 2.79 ± 0.37 | 2.57 ± 0.57 | |
PT (s) | 16.52 ± 0.82 | 16.00 ± 1.20 | 16.27 ± 0.63 | 16.57 ± 1.29 |
∗Means P < 0.05; ∗∗means P < 0.01; n means the number of animals.
Compared with control group, the mean corpuscular volume (MCV) of male rats in low and medium dose groups and the mean corpuscular hemoglobin (MCH) of male rats in medium dose group were significantly decreased (P < 0.05 or P < 0.01). The RBC, HGB, and HCT in serum, however, were normal and the change extents of MCV and MCH were in a narrow range and no abnormalities were found in high dose group but the RBC was significantly elevated (P < 0.05).
Prothrombin times of rats in each group were approximately the same (P > 0.05) and were in normal range.
As a result, 3-month consecutive oral administration of MLE caused no obvious influences to the hematology and coagulation function of rats.
3.2.4. Biochemical Parameters
Serum levels of TG and CHOL of the male rats in high dose group were significantly higher (P < 0.05) than that of control group. Among the female rats, the AST and TBIL levels in high dose group were significantly lower (P < 0.05) but within a narrow range than the controls, which means no toxicological significance. Moreover, a lower serum K+ level was detected in female rats in high dose group (P < 0.05); in addition, no other biochemical parameters were found abnormal (Table 5).
Table 5.
Sex | Parameters | Control group (n = 6) | Low-dose group (n = 6) | Medium-dose group (n = 6) | High-dose group (n = 6) |
---|---|---|---|---|---|
♂ | ALT (U/L) | 33.85 ± 5.16 | 40.90 ± 12.38 | 34.50 ± 4.71 | 34.82 ± 3.32 |
AST (U/L) | 143.57 ± 32.64 | 164.42 ± 49.16 | 144.92 ± 15.15 | 152.03 ± 48.87 | |
ALP (U/L) | 83.73 ± 11.32 | 91.22 ± 30.39 | 83.65 ± 18.66 | 82.45 ± 17.09 | |
BUN (mmol/L) | 6.22 ± 0.64 | 6.35 ± 0.73 | 6.72 ± 0.60 | 6.12 ± 0.57 | |
CREA (μmol/L) | 73.67 ± 7.55 | 70.35 ± 3.17 | 76.50 ± 3.31 | 72.05 ± 5.29 | |
TP (g/L) | 57.53 ± 4.49 | 59.52 ± 1.09 | 59.22 ± 1.26 | 59.87 ± 3.34 | |
ALB (g/L) | 22.90 ± 1.28 | 23.43 ± 0.74 | 23.67 ± 0.74 | 24.25 ± 0.90 | |
GLU (mmol/L) | 10.14 ± 1.07 | 8.93 ± 1.13 | 10.35 ± 1.88 | 9.25 ± 0.93 | |
CHOl (mmol/L) | 1.36 ± 0.26 | 1.78 ± 0.38 | 1.50 ± 0.39 | 1.74 ± 0.23* | |
TBIL (μmol/L) | 2.34 ± 0.16 | 2.44 ± 0.28 | 2.39 ± 0.24 | 2.35 ± 0.15 | |
TG (mmol/L) | 0.41 ± 0.16 | 0.48 ± 0.17 | 0.56 ± 0.28 | 0.64 ± 0.18* | |
CK (U/L) | 775.18 ± 354.51 | 812.22 ± 295.98 | 817.42 ± 143.23 | 795.83 ± 221.83 | |
Na+ (mmol/L) | 139.62 ± 2.32 | 140.77 ± 2.27 | 139.65 ± 1.74 | 139.88 ± 0.37 | |
K+ (mmol/L) | 4.52 ± 0.45 | 4.73 ± 0.19 | 4.58 ± 0.25 | 4.65 ± 0.30 | |
Cl− (mmol/L) | 104.00 ± 1.37 | 104.12 ± 1.40 | 102.90 ± 1.88 | 103.30 ± 1.11 | |
| |||||
♀ | ALT (U/L) | 26.35 ± 3.31 | 29.80 ± 4.60 | 25.98 ± 3.80 | 24.93 ± 4.54 |
AST (U/L) | 137.12 ± 18.95 | 128.62 ± 21.23 | 129.70 ± 23.13 | 114.12 ± 14.57* | |
ALP (U/L) | 42.28 ± 9.34 | 48.72 ± 13.80 | 43.47 ± 6.99 | 47.52 ± 10.20 | |
BUN (mmol/L) | 7.67 ± 0.64 | 7.84 ± 0.74 | 7.56 ± 0.99 | 6.87 ± 1.31 | |
CREA (μmol/L) | 74.63 ± 4.22 | 76.52 ± 4.24 | 79.57 ± 4.44 | 73.15 ± 4.37 | |
TP (g/L) | 65.97 ± 3.99 | 67.60 ± 3.47 | 67.98 ± 6.41 | 65.13 ± 3.23 | |
ALB (g/L) | 29.37 ± 2.71 | 30.25 ± 1.94 | 30.57 ± 2.82 | 28.45 ± 2.26 | |
GLU (mmol/L) | 7.96 ± 1.08 | 8.92 ± 1.00 | 8.93 ± 1.41 | 8.76 ± 1.00 | |
CHOl (mmol/L) | 1.72 ± 0.19 | 1.79 ± 0.50 | 1.79 ± 0.43 | 1.63 ± 0.20 | |
TBIL (μmol/L) | 2.69 ± 0.20 | 2.68 ± 0.15 | 2.76 ± 0.43 | 2.42 ± 0.21* | |
TG (mmol/L) | 0.32 ± 0.06 | 0.34 ± 0.06 | 0.30 ± 0.06 | 0.31 ± 0.07 | |
CK (U/L) | 607.28 ± 213.08 | 568.75 ± 167.69 | 670.88 ± 153.16 | 612.25 ± 136.05 | |
Na+ (mmol/L) | 139.87 ± 1.30 | 140.55 ± 1.07 | 140.87 ± 1.24 | 139.68 ± 0.92 | |
K+ (mmol/L) | 4.35 ± 0.31 | 4.18 ± 0.34 | 3.98 ± 0.23* | 4.04 ± 0.32 | |
Cl− (mmol/L) | 104.92 ± 2.49 | 104.95 ± 0.36 | 104.82 ± 1.21 | 103.82 ± 0.60 |
∗Means P < 0.05; n means the number of animals.
3.2.5. Relative Organ Weight
The effects of MLE on the relative organ weights of male rats are presented in Table 6. Compared with control group, epididymis weight in medium and high dose groups were significantly higher (P < 0.05 or P < 0.01) and epididymis/brain weight ratio in high dose group was significantly different (P < 0.05), while the organ/body weight ratio revealed no marked differences (P > 0.05). The fat weight and the relative fat weight were higher but produced no remarkable differences than the controls (P > 0.05) and there were no obvious changes with the increasing of the dosage of MLE. Besides, all the other organ weights were normal.
Table 6.
Parameters | Control group (n = 6) | Low dose group (n = 6) | Medium dose group (n = 6) | High dose group (n = 6) |
---|---|---|---|---|
Organ weight (g) | ||||
Heart | 1.720 ± 0.311 | 1.715 ± 0.312 | 1.669 ± 0.127 | 1.640 ± 0.189 |
Liver | 12.370 ± 1.468 | 12.673 ± 2.428 | 12.803 ± 2.070 | 13.091 ± 2.106 |
Spleen | 0.783 ± 0.099 | 0.847 ± 0.121 | 0.788 ± 0.053 | 0.816 ± 0.124 |
Lung | 1.623 ± 0.070 | 1.666 ± 0.215 | 1.711 ± 0.163 | 1.701 ± 0.147 |
Kidney | 3.229 ± 0.418 | 3.040 ± 0.300 | 3.090 ± 0.318 | 3.207 ± 0.450 |
Brain | 2.024 ± 0.057 | 2.138 ± 0.113 | 2.120 ± 0.123 | 2.058 ± 0.074 |
Adrenal gland | 0.063 ± 0.010 | 0.062 ± 0.013 | 0.070 ± 0.008 | 0.070 ± 0.006 |
Thymus | 0.397 ± 0.106 | 0.317 ± 0.064 | 0.396 ± 0.087 | 0.347 ± 0.038 |
Testis | 3.348 ± 0.302 | 3.587 ± 0.293 | 3.529 ± 0.367 | 3.571 ± 0.320 |
Epididymis | 1.557 ± 0.096 | 1.700 ± 0.121* | 1.647 ± 0.208 | 1.787 ± 0.135** |
Fat | 14.949 ± 3.320 | 17.607 ± 5.071 | 18.648 ± 8.385 | 17.647 ± 4.952 |
Organ/body weight ratio (mg/g) | ||||
Weight | 514.2 ± 41.1 | 514.8 ± 55.9 | 520.0 ± 51.1 | 525.7 ± 59.0 |
Heart | 3.335 ± 0.440 | 3.356 ± 0.696 | 3.217 ± 0.121 | 3.125 ± 0.218 |
Liver | 24.012 ± 1.433 | 24.430 ± 2.333 | 24.504 ± 1.484 | 24.823 ± 1.562 |
Spleen | 1.519 ± 0.097 | 1.640 ± 0.101 | 1.521 ± 0.115 | 1.552 ± 0.158 |
Lung | 3.166 ± 0.174 | 3.233 ± 0.199 | 3.312 ± 0.406 | 3.249 ± 0.244 |
Kidney | 6.269 ± 0.502 | 5.924 ± 0.453 | 5.974 ± 0.718 | 6.095 ± 0.424 |
Brain | 3.953 ± 0.257 | 4.201 ± 0.587 | 4.114 ± 0.504 | 3.950 ± 0.406 |
Adrenal gland | 0.124 ± 0.021 | 0.121 ± 0.022 | 0.135 ± 0.016 | 0.133 ± 0.017 |
Thymus | 0.765 ± 0.164 | 0.622 ± 0.163 | 0.763 ± 0.176 | 0.664 ± 0.086 |
Testis | 6.571 ± 1.005 | 7.010 ± 0.657 | 6.840 ± 0.972 | 6.848 ± 0.845 |
Epididymis | 3.048 ± 0.349 | 3.317 ± 0.210 | 3.188 ± 0.472 | 3.426 ± 0.365 |
Fat | 28.878 ± 4.757 | 33.652 ± 6.862 | 34.940 ± 11.830 | 33.614 ± 8.958 |
Organ/brain weight ratio (g/g) | ||||
Brain | 2.024 ± 0.057 | 2.138 ± 0.113 | 2.120 ± 0.123 | 2.058 ± 0.074 |
Heart | 0.848 ± 0.140 | 0.810 ± 0.184 | 0.791 ± 0.090 | 0.797 ± 0.084 |
Liver | 6.100 ± 0.585 | 5.955 ± 1.240 | 6.083 ± 1.263 | 6.365 ± 1.017 |
Spleen | 0.386 ± 0.040 | 0.398 ± 0.065 | 0.373 ± 0.033 | 0.396 ± 0.057 |
Lung | 0.802 ± 0.031 | 0.781 ± 0.112 | 0.810 ± 0.097 | 0.826 ± 0.062 |
Kidney | 1.592 ± 0.172 | 1.428 ± 0.179 | 1.458 ± 0.123 | 1.556 ± 0.187 |
Adrenal gland | 0.031 ± 0.005 | 0.029 ± 0.007 | 0.033 ± 0.004 | 0.034 ± 0.003 |
Thymus | 0.196 ± 0.050 | 0.147 ± 0.024 | 0.188 ± 0.046 | 0.168 ± 0.017 |
Testis | 1.656 ± 0.166 | 1.679 ± 0.123 | 1.669 ± 0.189 | 1.734 ± 0.119 |
Epididymis | 0.770 ± 0.057 | 0.798 ± 0.080 | 0.781 ± 0.125 | 0.869 ± 0.063* |
Fat | 7.356 ± 1.451 | 8.266 ± 2.462 | 8.949 ± 4.533 | 8.578 ± 2.372 |
∗Means P < 0.05; ∗∗means P < 0.01; n means the number of animals.
The effects of MLE on the relative organ weights of female rats are presented in Table 7. Compared with control group, the liver/body weight ratio and the liver/brain weight ratio in medium dose group were remarkably different (P < 0.05), and in the high dose group, the kidney weight, the relative kidney weights, the adrenal gland weight, and the ratio of adrenal gland to brain weight were also significantly different (P < 0.05 or P < 0.01). While in the low and medium groups, the fat weight and the relative fat weights were higher but produced no remarkable differences than the controls (P > 0.05) and there were no obvious changes with the increasing of the dosage of MLE. All the other organ weights were normal.
Table 7.
Parameters | Control group (n = 6) | Low dose group (n = 6) | Medium dose group (n = 6) | High dose group (n = 6) |
---|---|---|---|---|
Organ weight (g) | ||||
Heart | 1.074 ± 0.162 | 1.059 ± 0.054 | 1.058 ± 0.100 | 1.092 ± 0.097 |
Liver | 6.629 ± 0.449 | 7.320 ± 1.076 | 7.342 ± 0.747 | 7.215 ± 1.015 |
Spleen | 0.484 ± 0.030 | 0.514 ± 0.058 | 0.470 ± 0.049 | 0.496 ± 0.073 |
Lung | 1.230 ± 0.098 | 1.223 ± 0.084 | 1.256 ± 0.064 | 1.280 ± 0.116 |
kidney | 1.751 ± 0.152 | 1.832 ± 0.169 | 1.875 ± 0.134 | 2.014 ± 0.227* |
Brain | 1.911 ± 0.054 | 1.905 ± 0.113 | 1.869 ± 0.084 | 1.905 ± 0.082 |
Adrenal gland | 0.064 ± 0.013 | 0.082 ± 0.017 | 0.070 ± 0.012 | 0.084 ± 0.013* |
Thymus | 0.266 ± 0.052 | 0.282 ± 0.074 | 0.308 ± 0.065 | 0.264 ± 0.096 |
Uterus | 0.726 ± 0.156 | 0.733 ± 0.107 | 0.756 ± 0.107 | 0.641 ± 0.184 |
Ovary | 0.186 ± 0.025 | 0.194 ± 0.030 | 0.174 ± 0.036 | 0.195 ± 0.028 |
Fat | 8.844 ± 2.096 | 9.452 ± 2.210 | 10.023 ± 4.202 | 8.612 ± 4.182 |
Organ/body weight ratio (mg/g) | ||||
Weight | 283.2 ± 13.8 | 286.5 ± 14.2 | 289.0 ± 26.4 | 291.8 ± 35.2 |
Heart | 3.791 ± 0.516 | 3.705 ± 0.283 | 3.666 ± 0.244 | 3.770 ± 0.440 |
Liver | 23.404 ± 0.952 | 25.490 ± 2.803 | 25.445 ± 1.930* | 24.696 ± 1.327 |
Spleen | 1.709 ± 0.079 | 1.793 ± 0.171 | 1.630 ± 0.130 | 1.702 ± 0.146 |
Lung | 4.341 ± 0.244 | 4.267 ± 0.190 | 4.364 ± 0.286 | 4.405 ± 0.269 |
kidney | 6.190 ± 0.561 | 6.388 ± 0.388 | 6.503 ± 0.327 | 6.919 ± 0.411* |
Brain | 6.757 ± 0.252 | 6.667 ± 0.568 | 6.509 ± 0.622 | 6.608 ± 0.872 |
Adrenal gland | 0.226 ± 0.043 | 0.286 ± 0.050 | 0.242 ± 0.035 | 0.294 ± 0.068 |
Thymus | 0.937 ± 0.163 | 0.986 ± 0.254 | 1.064 ± 0.197 | 0.900 ± 0.299 |
Uterus | 2.567 ± 0.557 | 2.563 ± 0.379 | 2.636 ± 0.438 | 2.190 ± 0.518 |
Ovary | 0.659 ± 0.102 | 0.682 ± 0.137 | 0.608 ± 0.153 | 0.674 ± 0.095 |
Fat | 31.288 ± 7.420 | 32.888 ± 6.624 | 33.915 ± 11.504 | 28.450 ± 11.684 |
Organ/brain weight ratio (g/g) | ||||
Brain | 1.911 ± 0.054 | 1.905 ± 0.113 | 1.869 ± 0.084 | 1.905 ± 0.082 |
Heart | 0.562 ± 0.081 | 0.559 ± 0.063 | 0.567 ± 0.060 | 0.573 ± 0.047 |
Liver | 3.468 ± 0.195 | 3.857 ± 0.622 | 3.926 ± 0.318* | 3.790 ± 0.526 |
Spleen | 0.253 ± 0.011 | 0.270 ± 0.029 | 0.252 ± 0.026 | 0.261 ± 0.042 |
Lung | 0.643 ± 0.050 | 0.643 ± 0.050 | 0.672 ± 0.023 | 0.673 ± 0.063 |
kidney | 0.916 ± 0.075 | 0.966 ± 0.119 | 1.005 ± 0.084 | 1.057 ± 0.103* |
Brain | 0.033 ± 0.006 | 0.043 ± 0.010 | 0.037 ± 0.006 | 0.044 ± 0.005** |
Adrenal gland | 0.139 ± 0.024 | 0.149 ± 0.041 | 0.165 ± 0.033 | 0.139 ± 0.053 |
Thymus | 0.380 ± 0.082 | 0.385 ± 0.049 | 0.406 ± 0.062 | 0.338 ± 0.104 |
Uterus | 0.098 ± 0.014 | 0.102 ± 0.018 | 0.094 ± 0.022 | 0.103 ± 0.016 |
Ovary | 4.645 ± 1.166 | 4.979 ± 1.183 | 5.390 ± 2.372 | 4.525 ± 2.194 |
∗Means P < 0.05; ∗∗means P < 0.01; n means the number of animals.
4. Conclusions
The acute toxicity study showed that MLE was safe at the maximum dose (18.4 g/kg) on ICR mice; animals behaved normally during the experiment and no gross lesions on major organs were examined.
Throughout the 3 consecutive months of oral administration of MLE at different doses (100 mg/kg, 300 mg/kg, and 900 mg/kg), rats in each group were normal in body weight and food consumption and various tests showed that higher serum TG and CHOL levels were found in male rats; lower serum K+ level was detected in female rats; the epididymis weight of male rats and the liver, kidney, and adrenal gland weights of female rats were found higher. In addition to this, all animals were normal in hematology, coagulation function, biochemical criteria, gross anatomy, and relative organs weight.
From the foregoing, in male rats, as the body and fat weight increased, the TG and CHOL levels increased; more attentions should be paid to body fat examination. Although the liver and kidney weights of rats were changed, no blood biochemistry changes were hence brought about.
Acknowledgments
This research was supported by Important Drug Develop of MOST, China, (2012ZX09103201-031) and Program for Tianjin Innovative Research Team in University (TD12-5033).
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
References
- 1.Singh UP, Singh DP, Singh M, et al. Characterization of phenolic compounds in some Indian mango cultivars. International Journal of Food Sciences and Nutrition. 2004;55(2):163–169. doi: 10.1080/09637480410001666441. [DOI] [PubMed] [Google Scholar]
- 2.Barreto JC, Trevisan MTS, Hull WE, et al. Characterization and quantitation of polyphenolic compounds in bark, kernel, leaves, and peel of mango (Mangifera indica L.) Journal of Agricultural and Food Chemistry. 2008;56(14):5599–5610. doi: 10.1021/jf800738r. [DOI] [PubMed] [Google Scholar]
- 3.Kanwal Q, Hussain I, Latif Siddiqui H, Javaid A. Antifungal activity of flavonoids isolated from mango (Mangifera indica L.) leaves. Natural Product Research. 2010;24(20):1907–1914. doi: 10.1080/14786419.2010.488628. [DOI] [PubMed] [Google Scholar]
- 4.Gebara SS, De Oliveira Ferreira W, Ré-Poppi N, Simionatto E, Carasek E. Volatile compounds of leaves and fruits of Mangifera indica var. coquinho (Anacardiaceae) obtained using solid phase microextraction and hydrodistillation. Food Chemistry. 2011;127(2):689–693. doi: 10.1016/j.foodchem.2010.12.123. [DOI] [PubMed] [Google Scholar]
- 5.Hannan A, Asghar S, Naeem T, et al. Antibacterial effect of mango (Mangifera indica Linn.) leaf extract against antibiotic sensitive and multi-drug resistant Salmonella typhi. Pakistan Journal of Pharmaceutical Sciences. 2013;26(4):715–719. [PubMed] [Google Scholar]
- 6.Zhang Y, Han L, Ge D, et al. Isolation, structural elucidation, MS profiling, and evaluation of triglyceride accumulation inhibitory effects of benzophenone C-glucosides from leaves of Mangifera indica L. Journal of Agricultural and Food Chemistry. 2013;61(8):1884–1895. doi: 10.1021/jf305256w. [DOI] [PubMed] [Google Scholar]
- 7.Zhang Y, Qian Q, Ge D, et al. Identification of benzophenone C-glucosides from mango tree leaves and their inhibitory effect on triglyceride accumulation in 3T3-L1 adipocytes. Journal of Agricultural and Food Chemistry. 2011;59(21):11526–11533. doi: 10.1021/jf2028494. [DOI] [PubMed] [Google Scholar]
- 8.Zhang Y, Liu X, Han L, Gao X, Liu E, Wang T. Regulation of lipid and glucose homeostasis by mango tree leaf extract is mediated by AMPK and PI3K/AKT signaling pathways. Food Chemistry. 2013;141(3):2896–2905. doi: 10.1016/j.foodchem.2013.05.121. [DOI] [PubMed] [Google Scholar]